Cell Therapeutics (CTIC) Sees Momentum Run-Up
Tweet Send to a FriendGet Alerts CTIC Hot Sheet
Trade CTIC Now!
Momentum traders are all over Cell Therapeutics, Inc. (NASDAQ: CTIC) Tuesday following Peregrine Pharmaceuticals' (NASDAQ: PPHM) 80% surge yesterday.
Shares of CTIC last traded at up 25% to $1.63. Volume is already more than 3x the full day norm.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Shares of CTIC last traded at up 25% to $1.63. Volume is already more than 3x the full day norm.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Tesla (TSLA) Ramps Higher (GM)
- UPDATE: Credit Suisse Upgrades SolarCity (SCTY) to Outperform
- Biodel (BIOD) Lifts Following Pump Article
Create E-mail Alert Related Categories
Momentum MoversLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

Up)